Skip to content
akaturk Academic measurement

Article detail · 2020 · article

The Effect of Prognostic Factors on Long-Term Protection in Breast Cancer

Journal Cureus
ISSN2168-8184
YÖKSİS OpenAlex Open access · diamond
Year2020
Citations3OpenAlex
Percentile%52.6
FWCI0.231.00 = world average

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueCureus
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

Objectıves Axillary lymph node involvement is considered to be one of the most important factors in the staging and survival of breast cancer. Recurrences in women with a negative axillary condition detected as a result of long patient follow-up have revealed the importance of other prognostic factors and many studies have begun. The aim of this study is to evaluate breast cancer patients and to investigate other factors affecting breast cancer. Materials and methods Patients with breast cancer who were operated in our clinic between January 2005 and June 2007 were included in the study. Demographic characteristics, tumor size, lymph node involvement, grade, histological type, the status of estrogen and progesterone receptors (ER and PR), type of surgery performed, and cerb-B2 receptor status were recorded retrospectively. Results The mortality rate of the ER (+) PR (+) group was significantly lower than that of the ER (-) PR (-) group (p<0.05). There was no statistically significant difference between the ER (+) PR (+) cases and the mortality rates of any positive cases (p>0.05). There was a statistically significant difference between survival rates according to cerb-B2 status (p<0.01); cerb-B2 was positive in all patients who died. In cerb-B2 positive cases, there was a statistically significant difference between survival rates according to the tumor stages (p <0.05). Conclusion As a result; preoperative and postoperative staging of all breast cancer patients who applied to surgery clinics should be performed. Prognostic factors should be determined and patients should be directed to post-surgical treatment according to this information. Axillary lymph involvement, number, tumor size, estrogen receptor, progesterone receptor, and cerb-B2 status are safe markers that can be used to determine prognosis in our series.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

3citationsOpenAlex · cited_by_count (cache / database)

2 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2023 Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapyCitations 6 · OpenAlex
  2. 2022 Relationship between pathological response and molecular subtypes in locally advanced breast cancer patients receiving neoadjuvant chemotherapyCitations 6 · OpenAlex

Authors

3
  1. TANER EVCİMİK 1
  2. MAHMUT SAİD DEĞERLİ 2
  3. TAYFUN BİLGİÇ İSTANBUL NİŞANTAŞI ÜNİVERSİTESİ 3